The knowledge of its role in breast cancer has been limited to the fact that it is ErbB2-responsive and that it contributes to invasion by upregulating CTSB and PRKCA (protein kinase C alpha) expression in various breast cancer cell lines13,39,45. This evidence concerns the gene ERBB2 and breast cancer.